Astoria Strategic Wealth’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
Other funds holding APYX
RI
ACM
CAC
PVI
HKAM
TFCM
RA
Astoria Strategic Wealth's APYX Position: Q3 2021 in Review
Astoria Strategic Wealth sold out of Apyx Medical (APYX) in Q3 2021, closing a stake of 10,428 shares — an estimated $95K sold.
Astoria Strategic Wealth first reported a position in APYX in Q4 2019 and held it in 7 quarters. The position peaked at $101K in Q1 2021. 74 funds tracked by Wall St. Rank hold APYX as of Q3 2021.
- Astoria Strategic Wealth reported no remaining Apyx Medical position as of Q3 2021 after selling out during the quarter.
- Astoria Strategic Wealth sold 10,428 Apyx Medical shares in Q3 2021, an estimated $95K.
- Astoria Strategic Wealth first reported a position in Apyx Medical in Q4 2019 and held it in 7 quarters.
- Astoria Strategic Wealth's Apyx Medical position peaked at $101K in Q1 2021.
- 74 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2021.
Based on Astoria Strategic Wealth's 13F filing for Q3 2021, filed 15 Nov 2021.